Top ten errors of statistical analysis in observational studies for cancer research-Reference-Cited by-同舟云学术

Top ten errors of statistical analysis in observational studies for cancer research

Published:2017-12-07 Issue:8 Volume:20 Page:954-965
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Carmona-Bayonas A.^ORCID,Jimenez-Fonseca P.^ORCID,Fernández-Somoano A.,Álvarez-Manceñido F.,Castañón E.,Custodio A.,de la Peña F. A.,Payo R. M.,Valiente L. P.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s12094-017-1817-9/fulltext.html

Reference73 articles.

1. Garcia-Albeniz X, Chan JM, Paciorek AT, Logan RW, Kenfield SA, Cooperberg MR, et al. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. J Clin Oncol. 2014;32(15):817–24.

2. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124.

3. Jager LR, Leek JT. An estimate of the science-wise false discovery rate and application to the top medical literature. Biostatistics. 2014;15(1):1–12.

4. John LK, Loewenstein G, Prelec D. Measuring the prevalence of questionable research practices with incentives for truth telling. Psychol Sci. 2012;23(5):524–32.

5. Baker M. 1500 scientists lift the lid on reproducibility. Nature. 2016;533(7604):452–4.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

2. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

3. Exploring the impact of the multimodal CAPABLE eHealth intervention on health-related quality of life in melanoma patients undergoing immune-checkpoint inhibition: A prospective pilot study (Preprint);2024-03-28

4. Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations;Current Opinion in Allergy & Clinical Immunology;2024-01-17

5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU;Revista Española de Enfermedades Digestivas;2024